A detailed history of Johnson Investment Counsel Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 18,728 shares of NVO stock, worth $2.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,728
Previous 18,363 1.99%
Holding current value
$2.1 Million
Previous $2.36 Million 13.41%
% of portfolio
0.03%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$122.71 - $146.91 $44,789 - $53,622
365 Added 1.99%
18,728 $2.67 Million
Q1 2024

May 09, 2024

SELL
$102.11 - $135.92 $279,679 - $372,284
-2,739 Reduced 12.98%
18,363 $2.36 Million
Q4 2023

Feb 07, 2024

BUY
$87.78 - $105.45 $98,840 - $118,736
1,126 Added 5.64%
21,102 $2.18 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $903,761 - $1.98 Million
9,938 Added 99.0%
19,976 $1.82 Million
Q2 2023

Aug 10, 2023

SELL
$155.98 - $172.65 $199,498 - $220,819
-1,279 Reduced 11.3%
10,038 $1.62 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $11,910 - $14,322
-90 Reduced 0.79%
11,317 $1.8 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $210,842 - $278,238
-2,056 Reduced 15.27%
11,407 $1.54 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $15,340 - $18,825
161 Added 1.21%
13,463 $1.34 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $30,765 - $36,299
-298 Reduced 2.19%
13,302 $1.48 Million
Q1 2022

May 11, 2022

BUY
$93.1 - $112.54 $1,675 - $2,025
18 Added 0.13%
13,600 $1.52 Million
Q4 2021

Feb 15, 2022

SELL
$95.88 - $117.08 $45,255 - $55,261
-472 Reduced 3.36%
13,582 $1.52 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $261,195 - $329,882
3,094 Added 28.23%
14,054 $1.35 Million
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $11,366 - $14,239
-168 Reduced 1.51%
10,960 $918,000
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $6,706 - $7,581
-100 Reduced 0.89%
11,128 $761,000
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $6,389 - $7,380
100 Added 0.9%
11,228 $784,000
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $81,956 - $95,116
-1,400 Reduced 11.17%
11,128 $729,000
Q1 2020

May 20, 2020

SELL
$49.46 - $64.78 $55,147 - $72,229
-1,115 Reduced 8.17%
12,528 $765,000
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $60,090 - $67,535
-1,264 Reduced 8.48%
13,643 $705,000
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $98,960 - $110,974
2,115 Added 16.53%
14,907 $760,000
Q1 2019

May 13, 2019

SELL
$46.36 - $52.63 $42,419 - $48,156
-915 Reduced 6.68%
12,792 $669,000
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $3,366 - $3,689
-72 Reduced 0.52%
13,707 $646,000
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $58,905 - $67,058
1,330 Added 10.68%
13,779 $635,000
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $13,092 - $15,697
-270 Reduced 2.12%
12,449 $613,000
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $5,323 - $6,017
112 Added 0.89%
12,719 $682,000
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $518,778 - $620,516
12,607
12,607 $607,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.